Enhanced hematopoietic growth factor production in an experimental myeloproliferative syndrome.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Blood

• Publication date

  1992-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V79.12.3179.3179PMID 1375844
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Hematopoietic growth factors].

  1993cited by this paper
• The role of interleukin-1 and granulocyte-macrophage colony-stimulating factor in the paracrine stimulation of an in vivo-derived murine myeloid leukemia.

  1991cited by this paper
• Structure, biosynthesis and biological roles of monocyte-macrophage colony stimulating factor (CSF-1 or M-CSF).

  1991cited by this paper
• Hematopoietic growth factors.

  1991cited by this paper
• Cytokines in viral diseases.

  1991cited by this paper
• IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA.

  1990cited by this paper
• Steel locus defines new multipotent growth factor.

  1990cited by this paper
• Abrogation of the requirement for feeder cell interaction and T cell receptor stimulation of lymphocytes infected with retroviral vectors

  1990cited by this paper
• The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus.

  1990cited by this paper
• Increased circulating CSF-1 (M-CSF) in myeloproliferative disease: association with myeloid metaplasia and peripheral bone marrow extension.

  1989cited by this paper
• Haemopoietic growth factors 1.

  1989cited by this paper
• Simultaneous production of interleukin 6, interferon‐β and colony‐stimulating activity by fibroblasts after viral and bacterial infection

  1989cited by this paper
• Clinical use of recombinant human hematopoietic growth factors.

  1989cited by this paper
• Peptide regulatory factors. Haemopoietic growth factors 1

  1989cited by this paper
• A Laboratory manual

  1989cited by this paper
• The cytokine network.

  1989cited by this paper
• Regulation of granulocyte- and monocyte-colony stimulating factor mRNA levels in human blood monocytes is mediated primarily at a post-transcriptional level.

  1989cited by this paper
• Simultaneous production of interleukin 6, interferon-beta and colony-stimulating activity by fibroblasts after viral and bacterial infection.

  1989cited by this paper
• Retrovirus-mediated transfer and expression of the interleukin-3 gene in mouse hematopoietic cells result in a myeloproliferative disorder

  1989cited by this paper
• A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing granulocyte‐macrophage colony stimulating factor.

  1989cited by this paper
• Interleukin-6 and granulocyte-macrophage colony-stimulating factor are candidate growth factors for chronic myelomonocytic leukemia cells.

  1989cited by this paper
• Tissue distribution of murine hemopoietic growth factor mRNA production

  1989cited by this paper
• Activation of multiple hemopoietic growth factor genes in Abelson virus-transformed myeloid cells.

  1988cited by this paper
• Granulocyte colony-stimulating factor enhances interleukin 3-dependent proliferation of multipotential hemopoietic progenitors.

  1988cited by this paper
• Stimulation of murine colony-forming cells with high proliferative potential by the combination of GM-CSF and CSF-1.

  1988cited by this paper
• Stimulation of murine colony-forming cells with high proliferative potential by the combination of GM-CSF and CSF-1

  1988cited by this paper
• Production of colony-stimulating factors (CSFs) during infection: separate determinations of macrophage-, granulocyte-, granulocyte-macrophage-, and multi-CSFs

  1988cited by this paper
• cDNA cloning and expression of murine macrophage colony-stimulating factor from L929 cells.

  1988cited by this paper
• cDNA cloning of murine interleukin‐HP1: homology with human interleukin 6

  1988cited by this paper
• Synergism between interleukin-6 and interleukin-3 in supporting proliferation of human hematopoietic stem cells: comparison with interleukin-1 alpha.

  1988cited by this paper
• Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors

  1988cited by this paper
• CACHECTIN: MORE THAN A TUMOR NECROSIS FACTOR

  1988cited by this paper
• Development and characterization of monoclonal antibodies to murine macrophage colony-stimulating factor.

  1988cited by this paper
• Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis

  1988cited by this paper
• Recombinant murine granulocyte‐macrophage (GM) colony‐stimulating factor supports formation of GM and multipotential blast cell colonies in culture: Comparison with the effects of interleukin‐3

  1987cited by this paper
• Abnormal splenic megakaryopoiesis in MPSV-induced myeloproliferative disease.

  1987cited by this paper
• Transforming genes and target cells of murine spleen focus-forming viruses.

  1987cited by this paper
• Cachectin: more than a tumor necrosis factor.

  1987cited by this paper
• A simple sensitive bioassay for interleukin-1 which is unresponsive to 10(3) U/ml of interleukin-2.

  1987cited by this paper
• Nature and specificity of lymphokine independence induced by a selectable retroviral vector expressing v-src

  1987cited by this paper
• The v-fms oncogene induces factor-independent growth and transformation of the interleukin-3-dependent myeloid cell line FDC-P1.

  1987cited by this paper
• Autocrine stimulation after transfer of the granulocyte/macrophage colony-stimulating factor gene and autonomous growth are distinct but interdependent steps in the oncogenic pathway.

  1987cited by this paper
• Automated chemical synthesis of a protein growth factor for hemopoietic cells, interleukin-3.

  1986cited by this paper
• Ectopic hematopoiesis in peritoneal tumor nodules induced by the myeloproliferative sarcoma virus in DBA/2 mice.

  1986cited by this paper
• Isolation from the spleen of myeloproliferative sarcoma virus-infected mice of a myelomonocytic tumor cell line secreting hematopoietic colony stimulating factors.

  1986cited by this paper
• Truncation of the c-myb gene by a retroviral integration in an interleukin 3-dependent myeloid leukemia cell line.

  1986cited by this paper
• A growth-factor dependent B-cell hybridoma.

  1986cited by this paper
• Isolation and characterization of the cDNA for murine granulocyte colony-stimulating factor.

  1986cited by this paper
• Tumor necrosis factor (TNF).

  1985cited by this paper
• Guidelines for immunoassay data processing.

  1985cited by this paper
• Structure and expression of the mRNA for murine granulocyte‐macrophage colony stimulating factor.

  1985cited by this paper
• Induction of IL 2 responsiveness in a murine IL 3-dependent cell line.

  1985cited by this paper
• Interleukin 3 promotes the in vitro proliferation of murine pluripotent hematopoietic stem cells.

  1985cited by this paper
• In vitro induction of CFU-S proliferation by a non viral splenic activity from myeloproliferative sarcoma virus infected mice.

  1985cited by this paper
• Cloning and expression of murine interleukin-1 cDNA in Escherichia coli

  1984cited by this paper
• Purification to apparent homogeneity of a factor stimulating the growth of multiple lineages of hemopoietic cells.

  1984cited by this paper
• Isolation and characterization of a mouse cDNA clone that expresses mast-cell growth-factor activity in monkey cells.

  1984cited by this paper
• Myeloproliferative syndrome induced by MPSV in DBA/2 mice: presence of a mixed-colonies promoting activity (MPA) in the spleen.

  1983cited by this paper
• Hematopoietic precursors in disease induced by the myeloproliferative sarcoma virus.

  1983cited by this paper
• Autogenous production of a hemopoietic growth factor, persisting-cell-stimulating factor, as a mechanism for transformation of bone marrow-derived cells.

  1983cited by this paper
• Myeloproliferative sarcoma virus: Its effects on erythropoiesis in adult DBA/2J mice

  1983cited by this paper
• Characterization and partial purification of a haemopoietic cell growth factor in WEHI-3 cell conditioned medium.

  1983cited by this paper
• A study of added GM-CSF independent granulocyte and macrophage precursors in mouse spleen infected with myeloproliferative sarcoma virus (MPSV).

  1982cited by this paper
• Identification in culture of a class of hemopoietic colony-forming units with extensive capability to self-renew and generate multipotential hemopoietic colonies.

  1982cited by this paper
• Retroviruses induce granulocyte–macrophage colony stimulating activity in fibroblasts

  1982cited by this paper
• Effects of myeloproliferative sarcoma virus on the pluripotential stem cell and granulocyte precursor cell populations of DBA/2 mice.

  1981cited by this paper
• Growth of factor-dependent hemopoietic precursor cell lines

  1980cited by this paper
• Strategies for the Analysis of Accessory‐Cell Function: The in vitro Cloning and Characterization of the P Cell

  1980cited by this paper
• Study of a virus-induced myeloproliferative syndrome associated with tumor formation in mice.

  1980cited by this paper
• Myeloproliferative virus, a cloned murine sarcoma virus with spleen focus-forming properties in adult mice

  1980cited by this paper
• Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

  1979cited by this paper
• Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange.

  1977cited by this paper
• Biological, pathological and physical characterization of a possible variant of a murine sarcoma virus (Moloney)

  1968cited by this paper

• Interleukin‐10 inhibits autonomous myelopoiesis in patients with myelofibrosis

  2015cites this paper
• High spontaneous granulocyte/macrophage-colony formation in patients with myelofibrosis.

  2014cites this paper
• Rôle du couple Flt3-ligand/Flt3 et de l'activation des "Mitogen-activated protein kinases" p38 dans la dysmégacaryopoïèse des patients atteints de myélofibrose primitive

  2011cites this paper
• Animal Models of Myelofibrosis

  2008cites this paper
• Cellular and molecular mechanisms underlying bone marrow and liver fibrosis: a review.

  2008cites this paper
• Thalidomide therapy for myelofibrosis with myeloid metaplasia

  2006cites this paper
• Lenalidomide therapy in myelofibrosis with myeloid metaplasia.

  2006cites this paper
• Association of Plasma Adiponectin Concentrations with Chronic Lymphocytic Leukemia and Myeloproliferative Diseases

  2006cites this paper
• Experimental myelofibrosis in mice and the implications to human disease.

  2005cites this paper
• Durable responses to thalidomide-based drug therapy for myelofibrosis with myeloid metaplasia.

  2004cites this paper
• Etiology of the myeloproliferative disorders: the role of thrombopoietin.

  2003cites this paper
• Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors.

  2002cites this paper
• Recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein Enbrel in patients with refractory hematologic malignancies

  2002influential citation
• Métaplasie myéloïde primitive avec myélofibrose

  2001cites this paper
• Myelofibrosis: pathogenesis of myelofibrosis with myeloid metaplasia

  2000cites this paper
• Dual implication of fibrogenic cytokines in the pathogenesis of fibrosis and myeloproliferation in myeloid metaplasia with myelofibrosis

  1999cites this paper
• Polycythemia vera megakaryocytes store and release lysozyme to a higher extent than megakaryocytes in secondary polycythemia (polyglobuly).

  1999cites this paper
• Myelofibrosis: pathogenesis of myelofibrosis with myeloid metaplasia. French INSERM Research Network on Myelofibrosis with Myeloid Metaplasia.

  1999cites this paper
• Serum beta-2-microglobulin, TNF-alpha and interleukins in myeloproliferative disorders.

  1999cites this paper
• Serum beta‐2‐microglobulin, TNF‐α and interleukins in myeloproliferative disorders

  1999cites this paper
• Polycythemia vera megakaryocytes but not megakaryocytes from normal controls and patients with smokers polyglobuly spontaneously express IL-6 and IL-6R and secrete IL-6

  1999cites this paper
• Pathogenesis and management of idiopathic myelofibrosis.

  1998cites this paper
• 3 Pathogenesis and management of idiopathic myelofibrosis

  1998cites this paper
• CD44 and hyaluronan binding by human myeloid cells.

  1996cites this paper
• [Two patients with idiopathic pulmonary fibrosis and monoclonal gammopathy].

  1996cites this paper
• Splénomégalie myéloïde

  1995cites this paper
• PATHOGENESIS OF IDIOPATHIC MYELOFIBROSIS: PRESENT STATUS AND FUTURE DIRECTIONS

  1994cites this paper
• Monocyte adhesion in patients with bone marrow fibrosis is required for the production of fibrogenic cytokines. Potential role for interleukin-1 and TGF-beta.

  1994cites this paper
• Serum levels of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in treated patients with chronic myelogenous leukemia in chronic phase.

  1994cites this paper
• Hemoglobin F synthesis is not restricted to fetal erythropoietic organs during extramedullary hematopoiesis.

  1994cites this paper
• Spontaneous megakaryocyte colony formation in myeloproliferative disorders is not neutralizable by antibodies against IL3, IL6 and GM‐CSF

  1994cites this paper
• Structure-function analysis of the C-terminal segment of human interleukin-6.

  1993cites this paper
• Increased synthesis of extracellular spleen glycosaminoglycans in an experimental myeloproliferative syndrome.

  1992cites this paper